250HO01043 AIKMAN

Print/PDF
Registration Name GEN-I-BEQ AIKMAN-ET
Registration Number HOCAN000106807394
Primary NAAB Code 250HO01043
Secondary Code(s)
Status Inactive
Controller Name Genervations (250)
Date of Birth 10/6/2011
aAa -
DMS -
GFI 8.8%
Genetic Codes * RC TP TV TL TY TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T, HHR-C
Sire FLEVO GENETICS SNOWMAN-ET
MGS EMERALD-ACR-SA T-BAXTER
Beta Casein A1A1
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ -44, 92% R CM$ -20
NM Percentile 15% FM$ -98
GTPI 2378 GM$ -66
PRODUCTION TRAITS
6021 Dtrs 2233 herds 20 % US 99% R
Milk -494 Fat, % 10 , +0.12%
SCS 2.94, 99% R Protein, % 1 , +0.07%
Feed Saved 56 , 62% R Milking Speed 6.55 , 74% R
Health & Fertility
Productive Life -2.0      97% R Mastitis -0.1      94% R
Heifer Livability -0.2       79% R Metritis -0.4      86% R
Livability 0.8      93% R D. Abom -0.5      91% R
DPR -1.7      98% R Ketosis -0.6      86% R
FSC -4.6      98% R R. Placenta 0.0      87% R
HCR 1.6      95% R Milk Fever 0.0      77% R
CCR -3.1      98% R
SCR -        -
DIA -       53% R
RSP -0.7      65% R
Calving Traits
Sire CE 1.5      98% R 6608 Obs
Daughter CE 2.7      97% R 1018 Obs, 2759 Dtrs
Sire SB 3.9      95% R 8196 Obs
Daughter SB 7.5      96% R 961 Obs, Dtrs
Gestation Length -1.1      99% R 769 Obs, 4657 Dtrs
Early First Calving 3.2      96% R 341 Obs, 1016 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
2530 Dtrs 1123 herds 98% R
PTA Type -0.61 UDC -0.28
HCC 1.07 BWC 0.24
FLC 0.30
Linear Traits
Stature -0.78
Short
Strength 0.40
Weak
Body Depth 0.41
Deep
Dairy Form -0.50
Closed
Rump Angle 0.47
Sloped
Thurl Width -0.78
Sloped
Rear Legs-Side View -0.78
Narrow
Rear Legs-Rear View 0.67
Straight
Foot Angle -0.16
Low
Feet & Legs Score -0.02
Low
F.U. Attachment -0.37
Straight
Rear Udder Height -0.01
Low
Rear Udder Width 0.37
Wide
Udder Cleft 0.60
Strong
Udder Depth 0.67
Straight
Front Teat Placement 0.47
Close
Rear Teat Placement 1.01
Close
Teat Length 1.35
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO